|
1
|
Dash UC, Bhol NK, Swain SK, Samal RR,
Nayak PK, Raina V, Panda SK, Kerry RG, Duttaroy AK and Jena AB:
Oxidative stress and inflammation in the pathogenesis of
neurological disorders: Mechanisms and implications. Acta Pharm Sin
B. 15:15–34. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Colwell CS: Defining circadian disruption
in neurodegenerative disorders. J Clin Invest. 131:e1482882021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bawari S, Tewari D, Arguelles S, Sah AN,
Nabavi SF, Xu S, Vacca RA, Nabavi SM and Shirooie S: Targeting BDNF
signaling by natural products: Novel synaptic repair therapeutics
for neurodegeneration and behavior disorders. Pharmacol Res.
148:1044582019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iskusnykh IY, Zakharova AA, Kryl'Skii ED
and Popova TN: Aging, neurodegenerative disorders, and cerebellum.
Int J Mol Sci. 25:10182024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh A, Kukreti R, Saso L and Kukreti S:
Oxidative stress: A key modulator in neurodegenerative diseases.
Molecules. 24:15832019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ravi Singh J: Redox imbalance and
hypoxia-inducible factors: A multifaceted crosstalk. FEBS J.
292:3833–3848. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim S, Jung UJ and Kim SR: Role of
oxidative stress in blood-brain barrier disruption and
neurodegenerative diseases. Antioxidants (Basel). 13:14622024.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hajialyani M, Hosein Farzaei M, Echeverria
J, Nabavi SM, Uriarte E and Sobarzo-Sanchez E: Hesperidin as a
neuroprotective agent: A review of animal and clinical evidence.
Molecules. 24:6482019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kogure T, Suda M, Hiraga K and Inui M:
Protocatechuate overproduction by Corynebacterium glutamicum via
simultaneous engineering of native and heterologous biosynthetic
pathways. Metab Eng. 65:232–242. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim Y, Cho M, Lee JS, Oh J and Lim J:
Protocatechuic acid from euonymus alatus mitigates
scopolamine-induced memory impairment in mice. Foods. 13:26642024.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bozinou E, Georgiadou NT, Chalastara MS,
Makrygiannis I, Mantiniotou M, Athanasiadis V, Chatzilazarou A and
Lalas SI: Recovery of natural antioxidants from onion solid waste
via pressurized liquid extraction: Encapsulation and application
into a food system. Foods. 14:35832025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hamdi A, Jaramillo-Carmona S,
Rodriguez-Arcos R, Jimenez-Araujo A, Karray Bouraoui N and
Guillen-Bejarano R: Phytochemical profile and in vitro
bioactivities of wild asparagus stipularis. Molecules. 29:8172024.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Zheng T, Lian F, Xu T, Yin W and
Jiang Y: Anthocyanin-rich blueberry extracts and anthocyanin
metabolite protocatechuic acid promote autophagy-lysosomal pathway
and alleviate neurons damage in in vivo and in vitro models of
Alzheimer's disease. Nutrition. 93:1114732022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SH, Choi BY, Lee SH, Kho AR, Jeong JH,
Hong DK and Suh SW: Administration of protocatechuic acid reduces
traumatic brain injury-induced neuronal death. Int J Mol Sci.
18:25102017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghasemzadeh Rahbardar M and Hosseinzadeh
H: Neuroprotective effects of walnut (Juglans regia L.) in nervous
system disorders: A comprehensive review. Iran J Basic Med Sci.
27:1492–1505. 2024.PubMed/NCBI
|
|
16
|
Li R, Wang L, Zhang Q, Duan H, Qian D,
Yang F and Xia J: Alpiniae oxyphyllae fructus possesses
neuroprotective effects on H(2)O(2) stimulated PC12 cells via
regulation of the PI3K/Akt signaling pathway. Front Pharmacol.
13:9663482022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salama A, Elgohary R, Amin MM and Elwahab
SA: Immunomodulatory effect of protocatechuic acid on
cyclophosphamide induced brain injury in rat: Modulation of
inflammosomes NLRP3 and SIRT1. Eur J Pharmacol. 932:1752172022.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gallardo-Fernandez M, Hornedo-Ortega R,
Cerezo AB, Troncoso AM and Garcia-Parrilla MC: Melatonin,
protocatechuic acid and hydroxytyrosol effects on vitagenes system
against alpha-synuclein toxicity. Food Chem Toxicol.
134:1108172019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao H, Wang L, Zhang L and Zhao H:
Phytochemicals targeting lncRNAs: A novel direction for
neuroprotection in neurological disorders. Biomed Pharmacother.
162:1146922023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu H, Zhou L, Tang J, Xu Y, Wang W, Shi
W, Li Z, Zhang L, Ding Z, Xi K, et al: Reactive oxygen
species-responsive composite fibers regulate oxidative metabolism
through internal and external factors to promote the recovery of
nerve function. Small. 20:e24012412024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hill D, Compagnoni C and Cordeiro MF:
Investigational neuroprotective compounds in clinical trials for
retinal disease. Expert Opin Investig Drugs. 30:571–577. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang W, Xiao D, Wu C, Yang J, Peng X,
Chen L, Zhang J, Zha G, Li W, Ju R, et al: Circular RNA-based
therapy provides sustained and robust neuroprotection for retinal
ganglion cells. Mol Ther Nucleic Acids. 35:1022582024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nimgampalle M, Chakravarthy H, Sharma S,
Shree S, Bhat AR, Pradeepkiran JA and Devanathan V:
Neurotransmitter systems in the etiology of major neurological
disorders: Emerging insights and therapeutic implications. Ageing
Res Rev. 89:1019942023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rebas E, Rzajew J, Radzik T and Zylinska
L: Neuroprotective polyphenols: A modulatory action on
neurotransmitter pathways. Curr Neuropharmacol. 18:431–445. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou ZD, Yi LX, Wang DQ, Lim TM and Tan
EK: Role of dopamine in the pathophysiology of Parkinson's disease.
Transl Neurodegener. 12:442023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Daniels S, El Mansari M and Blier P: AMPA
receptors modulate enhanced dopamine neuronal activity induced by
the combined administration of venlafaxine and brexpiprazole.
Neuropsychopharmacol. 49:2042–2051. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soni U, Singh K, Jain D and Pujari R:
Exploring Alzheimer's disease treatment: Established therapies and
novel strategies for future care. Eur J Pharmacol. 998:1775202025.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Imai R, Tamura R, Yo M, Sato M, Fukumura
M, Takahara K, Kase Y, Okano H and Toda M: Neuroprotective effects
of genome-edited human iPS cell-derived neural stem/progenitor
cells on traumatic brain injury. Stem Cells. 41:603–616. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pischiutta F, Tribuzio F, Magatti M, De
Simone G, Moro F, Nattino G, Signorini F, Loose L, Caruso E,
Bertani C, et al: Mesenchymal stromal cell secretome and its key
bioactive metabolites induce long-term neuroprotection after
traumatic brain injury in mice. Adv Sci (Weinh). 12:e155082025.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim JE, Ji YE, Hwang HJ, Go GE, Lim HJ,
Yoo J, Kim J, Park D, Kim EH, Kim D and Bang OY: Engineered MSC-EVs
loaded with BDNF-enhancing neuropeptides via a non-disruptive
method enhance post-stroke neuroregeneration via intranasal
delivery. J Nanobiotechnology. 23:5942025. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu G, Yang C, Wang X, Chen X, Cai H and
Le W: Cerebellum in neurodegenerative diseases: Advances,
challenges, and prospects. iScience. 27:1111942024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rudolph S, Badura A, Lutzu S, Pathak SS,
Thieme A, Verpeut JL, Wagner MJ, Yang YM and Fioravante D:
Cognitive-affective functions of the cerebellum. J Neurosci.
43:7554–7564. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Beeraka NM, Nikolenko VN, Khaidarovich ZF,
Valikovna OM, Aliagayevna RN, Arturovna ZL, Alexandrovich KA,
Mikhaleva LM and Sinelnikov MY: Recent investigations on the
functional role of cerebellar neural networks in motor functions
& nonmotor functions -neurodegeneration. Curr Neuropharmacol.
20:1865–1878. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tong L, Li MD, Nie PY, Chen Y, Chen YL and
Ji LL: miR-132 downregulation alleviates behavioral impairment of
rats exposed to single prolonged stress, reduces the level of
apoptosis in PFC, and upregulates the expression of MeCP2 and BDNF.
Neurobiol Stress. 14:1003112021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Yang G, Liang C, Li Y, Gao L, Liu
Y, Wang Y, Li J, Zhou Y, Han Z and Ren J: Nodakenin attenuates
cerebral ischemia-reperfusion injury by modulating the
PI3K/AKT/NF-κB signaling pathway. Immunopharm Immunot. 48:272–281.
2026. View Article : Google Scholar
|
|
36
|
Zhang T, Liu N, Cao H, Wei W, Ma L and Li
H: Different doses of pharmacological treatments for mild to
moderate alzheimer's disease: A bayesian network meta-analysis.
Front Pharmacol. 11:7782020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Lin S, Bai C, Zhang H, Liu H, Wang
M and Guo R: Exploring the risk of adverse drug events in
combination with antiparkinsonics and antipsychotics-a two-decade
real-world pharmacovigilance analysis based on the FAERS database.
Int J Neuropsychopharmacol. 28:pyaf332025. View Article : Google Scholar
|
|
38
|
Wen X, Lan T, Su W, Cao B, Wang Y and Chen
Y: Latest progress and challenges in drug development for
degenerative motor neuron diseases. Neural Regen Res. 21:1849–1863.
2026. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dodson K, Livezey S, Denson B, Choi L,
DeClercq J, Zuckerman AD and Johnson K: Deutetrabenazine treatment
outcomes with doses above U.S. Food and Drug Administration maximum
approved doses in Huntington's disease chorea: A dual-site
analysis. J Huntingtons Dis. 14:140–148. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bayas A, Christ M, Faissner S, Klehmet J,
Pul R, Skripuletz T and Meuth SG: Disease-modifying therapies for
relapsing/active secondary progressive multiple sclerosis-a review
of population-specific evidence from randomized clinical trials.
Ther Adv Neurol Disord. 16:175628642211468362023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dang C, Wang Q, Zhuang Y, Li Q, Lu Y,
Xiong Y and Feng L: Synergistic effects of neuroprotective drugs
with intravenous recombinant tissue plasminogen activator in acute
ischemic stroke: A Bayesian network meta-analysis. PLoS One.
19:e3112312024. View Article : Google Scholar
|
|
42
|
French KF, White J and Hoesch RE:
Treatment of intracerebral hemorrhage with tranexamic acid after
thrombolysis with tissue plasminogen activator. Neurocrit Care.
17:107–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hua Y, Keep RF, Hoff JT and Xi G:
Deferoxamine therapy for intracerebral hemorrhage. Acta Neurochir
Suppl. 105:3–6. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huerta MÁ, Mayo-Moldes M, Garcia MM,
García-Parra B, Matute M, López-Tofiño Y, Paniagua N,
Hernández-Secorún M, Soler D, Salmerón M, et al: Prescription
trends and clinical decision-making in neuropathic pain
pharmacological treatment: Results from a cross-sectional survey by
the Spanish pain society. Eur J Pain. 30:e702462026. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chauvet-Gélinier JC: Efficacy of
escitalopram vs paroxetine on severe depression with associated
anxiety: Data from the ‘Boulenger’ study. Encephale. 36:425–432.
2010.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fava M, Dunner DL, Greist JH, Preskorn SH,
Trivedi MH, Zajecka J and Cohen M: Efficacy and safety of
mirtazapine in major depressive disorder patients after SSRI
treatment failure: an open-label trial. J Clin Psychiatry.
62:413–420. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jesus Palma AC, Antunes Júnior CR, Barreto
ESR, Alencar VB, Souza AKDN, Mathias CMC, Lins-Kusterer LEF, Azi
LMTA and Kraychete DC: Pharmacological treatment of
chemotherapy-induced neuropathy: A systematic review of randomized
clinical trials. Pain Manag Nurs. 26:249–263. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Subash S, Essa MM, Braidy N, Awlad-Thani
K, Vaishnav R, Al-Adawi S, Al-Asmi A and Guillemin GJ: Diet rich in
date palm fruits improves memory, learning and reduces beta amyloid
in transgenic mouse model of Alzheimer's disease. J Ayurveda Integr
Med. 6:111–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Krzysztoforska K, Mirowska-Guzel D and
Widy-Tyszkiewicz E: Pharmacological effects of protocatechuic acid
and its therapeutic potential in neurodegenerative diseases: Review
on the basis of in vitro and in vivo studies in rodents and humans.
Nutr Neurosci. 22:72–82. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zheng J, Xiong H, Li Q, He L, Weng H, Ling
W and Wang D: Protocatechuic acid from chicory is bioavailable and
undergoes partial glucuronidation and sulfation in healthy humans.
Food Sci Nutr. 7:3071–3080. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xiao T, Pan M, Wang Y, Huang Y, Tsunoda M,
Zhang Y, Wang R, Hu W, Yang H, Li LS and Song Y: In vitro
bloodbrain barrier permeability study of four main active
ingredients from Alpiniae oxyphyllae fructus. J Pharm Biomed Anal.
235:1156372023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Song J, He Y, Luo C, Feng B, Ran F, Xu H,
Ci Z, Xu R, Han L and Zhang D: New progress in the pharmacology of
protocatechuic acid: A compound ingested in daily foods and herbs
frequently and heavily. Pharmacol Res. 161:1051092020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Khan AK, Rashid R, Fatima N, Mahmood S,
Mir S, Khan S, Jabeen N and Murtaza G: Pharmacological activities
of protocatechuic acid. Acta Pol Pharm. 72:643–650. 2015.PubMed/NCBI
|
|
54
|
Liang S, Zhao Z, Liu L, Zhang Y and Liu X:
Research progress on the mechanisms of protocatechuic acid in the
treatment of cognitive impairment. Molecules. 29:47242024.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Munteanu C, Galaction AI, Turnea M,
Blendea CD, Rotariu M and Postaru M: Redox homeostasis, gut
microbiota, and epigenetics in neurodegenerative diseases: A
Systematic review. Antioxidants (Basel). 13:10622024. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang Z, Yang J, Zhou Q, Zhong S, Luo J,
Chai X, Liu J, Zhang X, Chang X and Wang H: The role and mechanism
of the cGAS-STING pathway-mediated ROS in apoptosis and ferroptosis
induced by manganese exposure. Redox Biol. 85:1037612025.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Moren C, deSouza RM, Giraldo DM and Uff C:
Antioxidant therapeutic strategies in neurodegenerative diseases.
Int J Mol Sci. 23:93282022. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gao H, Yuan X, Wang Z, Gao Q and Yang J:
Profiles and neuroprotective effects of Lycium ruthenicum
polyphenols against oxidative stress-induced cytotoxicity in PC12
cells. J Food Biochem. 44:e131122020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kho AR, Choi BY, Lee SH, Hong DK, Lee SH,
Jeong JH, Park KH, Song HK, Choi HC and Suh SW: Effects of
protocatechuic Acid (PCA) on global cerebral ischemia-induced
hippocampal neuronal death. Int J Mol Sci. 19:14202018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang Z, Li G, Szeto SSW, Chong CM, Quan
Q, Huang C, Cui W, Guo B, Wang Y, Han Y, et al: Examining the
neuroprotective effects of protocatechuic acid and chrysin on in
vitro and in vivo models of Parkinson disease. Free Radic Biol Med.
84:331–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Gao Y, Ma L, Han T, Wang M, Zhang D and
Wang Y: Protective role of protocatechuic acid in
sevoflurane-induced neuron apoptosis, inflammation and oxidative
stress in mice. Restor Neurol Neurosci. 38:323–331. 2020.PubMed/NCBI
|
|
62
|
Winter AN, Brenner MC, Punessen N,
Snodgrass M, Byars C, Arora Y and Linseman DA: Comparison of the
neuroprotective and anti-inflammatory effects of the anthocyanin
metabolites, protocatechuic acid and 4-hydroxybenzoic acid. Oxid
Med Cell Longev. 2017:62970802017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Shui Guan, Bao YM, Bo Jiang and An LJ:
Protective effect of protocatechuic acid from Alpinia oxyphylla on
hydrogen peroxide-induced oxidative PC12 cell death. Eur J
Pharmacol. 538:73–79. 2006. View Article : Google Scholar
|
|
64
|
An LJ, Guan S, Shi GF, Bao YM, Duan YL and
Jiang B: Protocatechuic acid from Alpinia oxyphylla against
MPP+-induced neurotoxicity in PC12 cells. Food Chem Toxicol.
44:436–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lanigan SM and O'Connor JJ: The hypoxia
mimetic protocatechuic acid ethyl ester inhibits synaptic signaling
and plasticity in the rat hippocampus. Neuroscience. 369:168–182.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Umeno A, Biju V and Yoshida Y: In vivo ROS
production and use of oxidative stress-derived biomarkers to detect
the onset of diseases such as Alzheimer's disease, Parkinson's
disease, and diabetes. Free Radic Res. 51:413–427. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Bourgognon JM, Spiers JG, Robinson SW,
Scheiblich H, Glynn P, Ortori C, Bradley SJ, Tobin AB and Steinert
JR: Inhibition of neuroinflammatory nitric oxide signaling
suppresses glycation and prevents neuronal dysfunction in mouse
prion disease. Proc Natl Acad Sci USA. 118:e20095791182021.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Weiner HL: Immune mechanisms and shared
immune targets in neurodegenerative diseases. Nat Rev Neurol.
21:67–85. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Abadin X, de Dios C, Zubillaga M, Ivars E,
Puigròs M, Marí M, Morales A, Vizuete M, Vitorica J, Trullas R, et
al: Neuroinflammation in age-related neurodegenerative diseases:
Role of mitochondrial oxidative stress. Antioxidants (Basel).
13:14402024. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Ravichandran KA and Heneka MT:
Inflammasomes in neurological disorders-mechanisms and therapeutic
potential. Nat Rev Neurol. 20:67–83. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Castro-Gomez S and Heneka MT: Innate
immune activation in neurodegenerative diseases. Immunity.
57:790–814. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Gao C, Jiang J, Tan Y and Chen S:
Microglia in neurodegenerative diseases: Mechanism and potential
therapeutic targets. Signal Transduct Target Ther. 8:3592023.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wang HY, Wang H, Wang JH, Wang Q, Ma QF
and Chen YY: Protocatechuic acid inhibits inflammatory responses in
LPS-Stimulated BV2 Microglia via NF-kappaB and MAPKs signaling
pathways. Neurochem Res. 40:1655–1660. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kaewmool C, Kongtawelert P, Phitak T,
Pothacharoen P and Udomruk S: Protocatechuic acid inhibits
inflammatory responses in LPS-activated BV2 microglia via
regulating SIRT1/NF-kappaB pathway contributed to the suppression
of microglial activation-induced PC12 cell apoptosis. J
Neuroimmunol. 341:5771642020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Xi Z, Xu C, Chen X, Wang B, Zhong Z, Sun
Q, Sun Y and Bian L: Protocatechuic acid suppresses microglia
activation and facilitates M1 to M2 phenotype switching in
intracerebral hemorrhage mice. J Stroke Cerebrovasc Dis.
30:1057652021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
González de Llano D, Roldan M, Parro L,
Bartolome B and Moreno-Arribas MV: Activity of microbial-derived
phenolic acids and their conjugates against LPS-induced damage in
neuroblastoma cells and macrophages. Metabolites. 13:1082023.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Gluck L, Gerstein B and Kaunzner UW:
Repair mechanisms of the central nervous system: From axon
sprouting to remyelination. Neurotherapeutics. 22:e5832025.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Nicoletti VG, Pajer K, Calcagno D, Pajenda
G and Nogradi A: The role of metals in the neuroregenerative action
of BDNF, GDNF, NGF and other neurotrophic factors. Biomolecules.
12:10152022. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Guo W, Liu K, Wang Y, Ge X, Ma Y, Qin J,
Zhang C, Zhao Y and Shi C: Neurotrophins and neural stem cells in
posttraumatic brain injury repair. Animal Model Exp Med. 7:12–23.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wang K, Wang H, Wang J, Xie Y, Chen J, Yan
H, Liu Z and Wen T: System approaches reveal the molecular networks
involved in neural stem cell differentiation. Protein Cell.
3:213–224. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhang WJ and Chen D: Mesenchymal stem cell
transplantation plays a role in relieving cancer pain. Front
Pharmacol. 15:14837162024. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Jiang J, Dai C, Liu X, Dai L, Li R, Ma K,
Xu H, Zhao F, Zhang Z, He T, et al: Implantation of regenerative
complexes in traumatic brain injury canine models enhances the
reconstruction of neural networks and motor function recovery.
Theranostics. 11:768–788. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wei S, Dong J, Hu Q, Bai J, Gao X, Shan H,
Sheng L, Dai J, Tao L, Yan B and Zhou X: Advances in mesenchymal
stem cells and their derivatives for promoting peripheral nerve
regeneration. Burns Trauma. 13:tkaf272025. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ju DT, Liao HE, Shibu MA, Ho TJ, Padma VV,
Tsai FJ, Chung LC, Day CH, Lin CC and Huang CY: Nerve regeneration
potential of protocatechuic acid in RSC96 schwann cells by
induction of cellular proliferation and migration through
IGF-IR-PI3K-Akt signaling. Chin J Physiol. 58:412–419. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Xue XY, Lin LF, Xiao F, Pi T, Lai YC and
Luo HM: Neurotrophic effects of protocatechuic acid on neurite
outgrowth and survival in cultured cerebral cortical neurons of
newborn rat. Zhong Yao Cai. 34:567–572. 2011.(In Chinese).
PubMed/NCBI
|
|
86
|
Xue XY, Liao MJ, Lin LF, Zhang Z, Zhou XW,
Zhou X and Luo HM: Phosphorylation of Akt is involved in
protocatechuic acid-induced neurotrophic activity. Neurol Res.
34:901–907. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Ju DT, Kuo WW, Ho TJ, Paul CR, Kuo CH,
Viswanadha VP, Lin CC, Chen YS, Chang YM and Huang CY:
Protocatechuic acid from alpinia oxyphylla induces schwann cell
migration via ERK1/2, JNK and p38 activation. Am J Chin Med.
43:653–665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Guan S, Zhang XL, Ge D, Liu TQ, Ma XH and
Cui ZF: Protocatechuic acid promotes the neuronal differentiation
and facilitates survival of phenotypes differentiated from cultured
neural stem and progenitor cells. Eur J Pharmacol. 670:471–478.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Guan S, Ge D, Liu TQ, Ma XH and Cui ZF:
Protocatechuic acid promotes cell proliferation and reduces basal
apoptosis in cultured neural stem cells. Toxicol In Vitro.
23:201–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Solana-Manrique C, Sanz FJ,
Martinez-Carrion G and Paricio N: Antioxidant and neuroprotective
effects of carnosine: Therapeutic implications in neurodegenerative
diseases. Antioxidants (Basel). 11:8482022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Wilson DM III, Cookson MR, Van Den Bosch
L, Zetterberg H, Holtzman DM and Dewachter I: Hallmarks of
neurodegenerative diseases. Cell. 186:693–714. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Huang L, Zhong X, Qin S and Deng M:
Protocatechuic acid attenuates βsecretase activity and okadaic
acidinduced autophagy via the Akt/GSK3β/MEF2D pathway in PC12
cells. Mol Med Rep. 21:1328–1335. 2020.PubMed/NCBI
|
|
93
|
Krzysztoforska K, Piechal A, Blecharz-Klin
K, Pyrzanowska J, Joniec-Maciejak I, Mirowska-Guzel D and
Widy-Tyszkiewicz E: Administration of protocatechuic acid affects
memory and restores hippocampal and cortical serotonin turnover in
rat model of oral D-galactose-induced memory impairment. Behav
Brain Res. 368:1118962019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Song Y, Cui T, Xie N, Zhang X, Qian Z and
Liu J: Protocatechuic acid improves cognitive deficits and
attenuates amyloid deposits, inflammatory response in aged AβPP/PS1
double transgenic mice. Int Immunopharmacol. 20:276–281. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Li S, Li S, Semde R, Teng H, Shi M, Huang
L, Lou X, Jia B, Zhu H and Zhao Y: Protocatechuic acid improves
Alzheimer's disease by regulating the cholinergic synaptic
signaling pathway. Chem Biodivers. 22:e2024027712025. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Choi JR, Kim JH, Lee S, Cho EJ and Kim HY:
Protective effects of protocatechuic acid against cognitive
impairment in an amyloid beta-induced Alzheimer's disease mouse
model. Food Chem Toxicol. 144:1115712020. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Hornedo-Ortega R, Alvarez-Fernandez MA,
Cerezo AB, Richard T, Troncoso A and Garcia-Parrilla M:
Protocatechuic acid: Inhibition of fibril formation,
destabilization of preformed fibrils of amyloid-β and α-synuclein,
and neuroprotection. J Agric Food Chem. 64:7722–7732. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zhang HN, An CN, Xu M, Guo DA, Li M and Pu
XP: Protocatechuic acid inhibits rat pheochromocytoma cell damage
induced by a dopaminergic neurotoxin. Biol Pharm Bull.
32:1866–1869. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zhang HN, An CN, Zhang HN and Pu XP:
Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo.
Neurosci Lett. 474:99–103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Krzysztoforska K, Piechal A, Blecharz-Klin
K, Pyrzanowska J, Joniec-Maciejak I, Mirowska-Guzel D and
Widy-Tyszkiewicz E: Effect of protocatechuic acid on cognitive
processes and central nervous system neuromodulators in the
hippocampus, prefrontal cortex, and striatum of healthy rats. Nutr
Neurosci. 25:1362–1373. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Wu T, Fang X, Xu J, Jiang Y, Cao F and
Zhao L: Synergistic effects of ginkgolide B and protocatechuic acid
on the treatment of Parkinson's disease. Molecules. 25:39762020.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Angelopoulou E, Pyrgelis ES and Piperi C:
Neuroprotective potential of chrysin in Parkinson's disease:
Molecular mechanisms and clinical implications. Neurochem Int.
132:1046122020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Koza LA, Winter AN, Holsopple J,
Baybayon-Grandgeorge AN, Pena C, Olson JR, Mazzarino RC, Patterson
D and Linseman DA: Protocatechuic acid extends survival, improves
motor function, diminishes gliosis, and sustains neuromuscular
junctions in the hSOD1(G93A) mouse model of amyotrophic lateral
sclerosis. Nutrients. 12:18242020. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Gade M, Comfort N and Re DB: Sex-specific
neurotoxic effects of heavy metal pollutants: Epidemiological,
experimental evidence and candidate mechanisms. Environ Res.
201:1115582021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Hassani S and Esmaeili A: The
neuroprotective effects of ferulic acid in toxin-induced models of
Parkinson's disease: A review. Ageing Res Rev. 97:1022992024.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Al Olayan EM, Aloufi AS, AlAmri OD,
El-Habit OH and Abdel Moneim AE: Protocatechuic acid mitigates
cadmium-induced neurotoxicity in rats: Role of oxidative stress,
inflammation and apoptosis. Sci Total Environ. 723:1379692020.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Mert H, Kerem O, Mis L, Yildirim S and
Mert N: Effects of protocatechuic acid against cisplatin-induced
neurotoxicity in rat brains: An experimental study. Int J Neurosci.
134:725–734. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Li Z, Liu Y, Wang F, Gao Z, Elhefny MA,
Habotta OA, Abdel Moneim AE and Kassab RB: Neuroprotective effects
of protocatechuic acid on sodium arsenate induced toxicity in mice:
Role of oxidative stress, inflammation, and apoptosis. Chem Biol
Interact. 337:1093922021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Lee SH, Choi BY, Kho AR, Jeong JH, Hong
DK, Lee SH, Lee SY, Lee MW, Song HK, Choi HC and Suh SW: Protective
effects of protocatechuic acid on seizure-induced neuronal death.
Int J Mol Sci. 19:1872018. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Liu YM, Jiang B, Bao YM and An LJ:
Protocatechuic acid inhibits apoptosis by mitochondrial dysfunction
in rotenone-induced PC12 cells. Toxicol In Vitro. 22:430–437. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Guan S, Jiang B, Bao YM and An LJ:
Protocatechuic acid suppresses MPP+ -induced mitochondrial
dysfunction and apoptotic cell death in PC12 cells. Food Chem
Toxicol. 44:1659–1666. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Salami AT, Adebimpe MA, Olagoke OC, Iyiola
TO and Olaleye SB: Potassium bromate cytotoxicity in the Wister rat
model of chronic gastric ulcers: Possible reversal by
protocatechuic acid. J Food Biochem. 44:e135012020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Chen Y, Sun L, Shi H, Mao G, Zhao T, Feng
W, Yang L and Wu X: Protective effect of protocatechuic acid on
oxidative damage and cognitive impairment in Pb-Induced rats. Biol
Trace Elem Res. 202:5556–5571. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Adefegha SA, Oboh G, Omojokun OS and
Adefegha OM: Alterations of Na(+)/K(+)-ATPase, cholinergic and
antioxidant enzymes activity by protocatechuic acid in
cadmium-induced neurotoxicity and oxidative stress in Wistar rats.
Biomed Pharmacother. 83:559–568. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Singh N, Hazari PP, Mittal P, Yadav SK,
Kumar N, Mishra G, Dahiya S and Mishra AK: Role of selective
serotonin reuptake inhibitors, serotonin-norepinephrine reuptake
inhibitors and psychedelics in the treatment of major depressive
disorder: A perspective on mechanistic insight and current status.
Eur J Pharmacol. 1001:1777372025. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhang K, Zhao Y, Chen X, Li Y, Lan T,
Chang M, Wang W, Wang C, Zhuang X, Zhang B and Yu S: p53 promote
oxidative stress, neuroinflammation and behavioral disorders via
DDIT4-NF-ĸB signaling pathway. Redox Biol. 86:1038362025.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Thakare VN, Dhakane VD and Patel BM:
Attenuation of acute restraint stress-induced depressive like
behavior and hippocampal alterations with protocatechuic acid
treatment in mice. Metab Brain Dis. 32:401–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Orzelska-Gorka J, Dos Santos Szewczyk K,
Gawronska-Grzywacz M, Herbet M, Lesniak A, Bielenica A,
Bujalska-Zadrożny M and Biała G: Procognitive, anxiolytic, and
antidepressant-like properties of hyperoside and protocatechuic
acid corresponding with the increase in serum serotonin level after
prolonged treatment in mice. Pharmaceuticals (Basel). 16:16912023.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Thakare VN, Lakade SH, Mahajan MP,
Kulkarni YP, Dhakane VD, Harde MT and Patel BM: Protocatechuic acid
attenuates chronic unpredictable mild stress induced-behavioral and
biochemical alterations in mice. Eur J Pharmacol. 898:1739922021.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Thakare VN, Patil RR, Suralkar AA, Dhakane
VD and Patel BM: Protocatechuic acid attenuate depressive-like
behavior in olfactory bulbectomized rat model: Behavioral and
neurobiochemical investigations. Metab Brain Dis. 34:775–787. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Sur B, Kwon S, Hahm DH and Lee B: The
anxiolytic-like effects of protocatechuic acid in an animal model
of post-traumatic stress disorder. J Med Food. 25:495–502. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Adedara IA, Omole O, Okpara ES, Fasina OB,
Ayeni MF, Ajayi OM, Busari EO and Farombi EO: Impact of prepubertal
exposure to dietary protocatechuic acid on the
hypothalamic-pituitary-testicular axis in rats. Chem Biol Interact.
290:99–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Owumi SE, Adedara IA, Farombi EO and
Oyelere AK: Protocatechuic acid modulates reproductive dysfunction
linked to furan exposure in rats. Toxicology. 442:1525562020.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Orzelska-Gorka J, Szewczyk K,
Gawronska-Grzywacz M, Kędzierska E, Głowacka E, Herbet M, Dudka J
and Biała G: Monoaminergic system is implicated in the
antidepressant-like effect of hyperoside and protocatechuic acid
isolated from Impatiens glandulifera Royle in mice. Neurochem Int.
128:206–214. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Lan X, Wang Q, Liu Y, You Q, Wei W, Zhu C,
Hai D, Cai Z, Yu J, Zhang J and Liu N: Isoliquiritigenin alleviates
cerebral ischemia-reperfusion injury by reducing oxidative stress
and ameliorating mitochondrial dysfunction via activating the Nrf2
pathway. Redox Biol. 77:1034062024. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Li G, Xiao H, Zuo C, Xie H, Wang X, Wang
J, Liu Y, Hou Q, Sun G and Tian Y: N-butylphthalide (NBP) and
ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway
to inhibit ferroptosis and exert brain neuroprotectivity. Redox
Biol. 86:1038352025. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Khan H, Grewal AK, Kumar M and Singh TG:
Pharmacological postconditioning by protocatechuic acid attenuates
brain injury in ischemia-reperfusion (I/R) Mice model: implications
of nuclear factor erythroid-2-related factor pathway. Neuroscience.
491:23–31. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Kale S, Sarode LP, Kharat A, Ambulkar S,
Prakash A, Sakharkar AJ and Ugale RR: Protocatechuic acid prevents
early hour ischemic reperfusion brain damage by restoring imbalance
of neuronal cell death and survival proteins. J Stroke Cerebrovasc
Dis. 30:1055072021. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Xi Z, Chen X, Xu C, Wang B, Zhong Z, Sun
Q, Sun Y and Bian L: Protocatechuic acid attenuates brain edema and
blood-brain barrier disruption after intracerebral hemorrhage in
mice by promoting Nrf2/HO-1 pathway. Neuroreport. 31:1274–1282.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Xi Z, Hu X, Chen X, Yang Y, Ren J, Wang B,
Zhong Z, Sun Y, Yang GY, Sun Q and Bian L: Protocatechuic acid
exerts protective effects via suppression of the P38/JNK-NF-ĸB
signalling pathway in an experimental mouse model of intracerebral
haemorrhage. Eur J Pharmacol. 854:128–138. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Muley MM, Thakare VN, Patil RR, Bafna PA
and Naik SR: Amelioration of cognitive, motor and endogenous
defense functions with silymarin, piracetam and protocatechuic acid
in the cerebral global ischemic rat model. Life Sci. 93:51–57.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Ma L, Wang G, Chen Z, Li Z, Yao J, Zhao H,
Wang S, Ma Z, Chang H and Tian X: Modulating the p66shc signaling
pathway with protocatechuic acid protects the intestine from
ischemia-reperfusion injury and alleviates secondary liver damage.
ScientificWorldJournal. 2014:3876402014. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Mohsin M, Shams F, Li H, Alam A, Xia C,
Fan L, Cao Y, Jiang W, Nasir A, Khan S and Bai Q: Nanozymes in
neuropathic pain: strategies bridging oxidative stress,
mitochondrial repair, and neuroimmune modulation for targeted
therapy. J Neuroinflammation. 22:1562025. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Ashina S, Robertson CE, Srikiatkhachorn A,
Di Stefano G, Donnet A, Hodaie M, Obermann M, Romero-Reyes M, Park
YS, Cruccu G and Bendtsen L: Trigeminal neuralgia. Nat Rev Dis
Primers. 10:392024. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Wang J, Li M, Zhang Z, Duan Y, Zhang Z,
Liu H, Yang K and Liu J: Association between mental disorders and
trigeminal neuralgia: A cohort study and Mendelian randomization
analysis. J Headache Pain. 26:742025. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Cici MO and Bektas N: The effect of
protocatechuic acid on neuropathic pain and possible mechanism.
Indian J Pharmacol. 55:315–321. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Chang HX and Zhao YF: Protocatechuic acid
as an inhibitor of the JNK/CXCL1/CXCR2 pathway relieves neuropathic
pain in CCI rats. Bosn J Basic Med Sci. 22:217–228. 2022.PubMed/NCBI
|
|
138
|
Fulas OA, Laferriere A and Coderre TJ:
Novel Co-crystal of pentoxifylline and protocatechuic acid relieves
allodynia in rat models of peripheral neuropathic pain and CRPS by
alleviating local tissue hypoxia. Acs Chem Neurosci. 12:3855–3863.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Park CS, Lee JY, Choi HY, Ju BG, Youn I
and Yune TY: Protocatechuic acid improves functional recovery after
spinal cord injury by attenuating blood-spinal cord barrier
disruption and hemorrhage in rats. Neurochem Int. 124:181–192.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Tsai SJ and Yin MC: Anti-glycative and
anti-inflammatory effects of protocatechuic acid in brain of mice
treated by D-galactose. Food Chem Toxicol. 50:3198–3205. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Semaming Y, Sripetchwandee J, Sa-Nguanmoo
P, Pintana H, Pannangpetch P, Chattipakorn N and Chattipakorn SC:
Protocatechuic acid protects brain mitochondrial function in
streptozotocin-induced diabetic rats. Appl Physiol Nutr Metab.
40:1078–1081. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Krzysztoforska K, Piechal A, Wojnar E,
Blecharz-Klin K, Pyrzanowska J, Joniec-Maciejak I, Krzysztoforski J
and Widy-Tyszkiewicz E: Protocatechuic acid prevents some of the
memory-related behavioural and neurotransmitter changes in a
pyrithiamine-induced thiamine deficiency model of
wernicke-korsakoff syndrome in rats. Nutrients. 15:6252023.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Yin X, Zhang X, Lv C, Li C, Yu Y, Wang X
and Han F: Protocatechuic acid ameliorates neurocognitive functions
impairment induced by chronic intermittent hypoxia. Sci Rep.
5:145072015. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Li L, Liu S, Tang H, Song S, Lu L, Zhang P
and Li X: Effects of protocatechuic acid on ameliorating lipid
profiles and cardio-protection against coronary artery disease in
high fat and fructose diet fed in rats. J Vet Med Sci.
82:1387–1394. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Monk R and Connor B: Cell replacement
therapy for Huntington's disease. Adv Exp Med Biol. 1266:57–69.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Khezri MR and Ghasemnejad-Berenji M:
Icariin: A potential neuroprotective agent in Alzheimer's disease
and Parkinson's disease. Neurochem Res. 47:2954–2962. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Fani G, Mannini B, Vecchi G, Cascella R,
Cecchi C, Dobson CM, Vendruscolo M and Chiti F: Abeta oligomers
dysregulate calcium homeostasis by mechanosensitive activation of
AMPA and NMDA receptors. ACS Chem Neurosci. 12:766–781. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Chen W, Wang D, Wang L, Bei D, Wang J, See
WA, Mallery SR, Stoner GD and Liu Z: Pharmacokinetics of
protocatechuic acid in mouse and its quantification in human plasma
using LC-tandem mass spectrometry. J Chromatogr B Analyt Technol
Biomed Life Sci. 908:39–44. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Tang J, Wen C, Zheng S, Sun C, Wang F and
Guan S: Xanthan gum-based protocatechuic acid grafted carboxymethyl
chitosan hydrogel with injectable, spraying, self-healing, and
enhanced antioxidant properties. Biomed Mater. 20:0450062025.
View Article : Google Scholar
|
|
150
|
Esposito E, Li W, T Mandeville E, Park JH,
Şencan I, Guo S, Shi J, Lan J, Lee J, Hayakawa K, et al: Potential
circadian effects on translational failure for neuroprotection.
Nature. 582:395–398. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Vazquez-Flores AA, Mu Oz-Bernal ÓA,
Alvarez-Parrilla E, Rodriguez-Tadeo A, Martínez-Ruiz NDR and de la
Rosa LA: Identification of amino acids and polyphenolic metabolites
in human plasma by UHPLC-ESI-QTOF-MS/MS, after the chronic intake
of a functional meal in an elderly population. Foods. 13:24712024.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Cardoso AL, Teixeira LL, Hassimotto NMA,
Baptista SL, Copetti CLK, Rieger DK, Vieira FGK, Micke GA, Vitali
L, Assis MAA, et al: Kinetic profile of urine metabolites after
acute intake of a phenolic compounds-rich juice of Ju?ara (Euterpe
edulis Mart.) and antioxidant capacity in serum and erythrocytes: A
human study. Int J Mol Sci. 24:95552023. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Bohn SK, Myhrstad MCW, Thoresen M, Erlund
I, Vasstrand AK, Marciuch A, Carlsen MH, Bastani NE, Engedal K,
Flekkøy KM and Blomhoff R: Bilberry/red grape juice decreases
plasma biomarkers of inflammation and tissue damage in aged men
with subjective memory impairment -a randomized clinical trial. BMC
Nutr. 7:752021. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Shin S, Cho SH, Park D and Jung E:
Anti-skin aging properties of protocatechuic acid in vitro and in
vivo. J Cosmet Dermatol. 19:977–984. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Daré RG, Oliveira MM, Truiti MCT, Nakamura
CV, Ximenes VF and Lautenschlager SOS: Abilities of protocatechuic
acid and its alkyl esters, ethyl and heptyl protocatechuates, to
counteract UVB-induced oxidative injuries and photoaging in
fibroblasts L929 cell line. J Photochem Photobiol B.
203:1117712020. View Article : Google Scholar : PubMed/NCBI
|
